Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Jagede OA"'
Autor:
Gonzalez-Kozlova E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Huang HH; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Jagede OA; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Tuballes K; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Del Valle DM; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Kelly G; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Patel M; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Xie H; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Harris J; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Argueta K; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Nie K; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Barcessat V; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Moravec R; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., Altreuter J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kahl BS; Washington University School of Medicine, New York, New York., Ansell SM; Mayo Clinic, New York, New York., Yu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Cerami E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Lindsay JR; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; CIMAC-CIDC Network, Pipeline Development and Portal Integration, Dana-Farber Cancer Institute, Boston, Massachusetts., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kim-Schulze S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York., Diefenbach CS; Perlmutter Cancer Center, NYU Langone Health, New York, New York., Gnjatic S; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1726-1737.